Cancer Immune Therapy: Current and Future Strategies by Stuhler, Gernot, Walden, Peter - Amazon.ae
Gernot Stuhler's research works | University of Wuerzburg, Würzburg (JMU) and other places
Pre-clinical and Early Clinical Experience Using Dendritic Cells to Treat Human Malignancy
Postdoctoral Scientist for Antibody Production and Protein Engineering (f/m/g)
m4 Award Preisträger - m4-Award
Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML -
Weltkrebstag: Würzburger Forscher setzen auf Immuntherapie
On-target restoration of a split T cell-engaging antibody for precision immunotherapy | Nature Communications
PDF) Erratum: Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo | William Sessa - Academia.edu
Hemibodies – a new antibody format for cancer immunotherapy - BMBF GO-Bio
A helping hand from Hemibody | Drug Discovery News
12) Patent Application Publication (10) Pub. No.: US 2015/0079093 A1
Stuhler - Names Encyclopedia
Variant signaling topology at the cancer cell–T-cell interface induced by a two-component T-cell engager | Cellular & Molecular Immunology
On-target restoration of a split T cell-engaging antibody for precision immunotherapy. - Abstract - Europe PMC
Der Initiator Prof. Dr. Gernot Stuhler ist zurück am Universitätsklinikum
Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal: Cell
ABOUT US - 99designs-5d6bbd5555df1s Webseite!
Glossary - Cancer Immune Therapy - Wiley Online Library
ABOUT US - 99designs-5d6bbd5555df1s Webseite!
Cancer Immune Therapy: Current and Future Strategies - Google Books
Innovativ und erfolgreich beim "Preis der BioRegionen" - einBLICK - Online-Magazin der Universität Würzburg
Hemibodies vernichten Krebszellen - Kampf gegen Krebs e.V.
Stuhler - Names Encyclopedia
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features - Biology of Blood and Marrow Transplantation
